[1]于代华.Hcy对重组人促红素改善急性脑梗死患者认知功能障碍的影响[J].医学信息,2020,33(19):59.[doi:10.3969/j.issn.1006-1959.2020.19.018]
　YU Dai-hua.Effect of Hcy on Recombinant Human Erythropoietin to Improve Cognitive Dysfunction in Patients with Acute Cerebral Infarction[J].Medical Information,2020,33(19):59.[doi:10.3969/j.issn.1006-1959.2020.19.018]
点击复制

Hcy对重组人促红素改善急性脑梗死患者认知功能障碍的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年19期
页码:
59
栏目:
论著
出版日期:
2020-10-01

文章信息/Info

Title:
Effect of Hcy on Recombinant Human Erythropoietin to Improve Cognitive Dysfunction in Patients with Acute Cerebral Infarction
文章编号:
1006-1959（2020）19-0059-04
作者:
于代华
西北大学附属医院/西安市第三医院重症医学科，陕西 西安 710018
Author(s):
YU Dai-hua
Northwestern University Affiliated Hospital/Department of Intensive Medicine,Xi’an Third Hospital, Xi’an 710018,Shaanxi,China
关键词:
促红素; 同型半胱氨酸; 急性脑梗死; 认知功能障碍
Keywords:
Erythropoietin; Homocysteine; Acute cerebral infarction; Cognitive dysfunction
分类号:
R743.33
DOI:
10.3969/j.issn.1006-1959.2020.19.018
文献标志码:
A
摘要:
目的 探讨同型半胱氨酸（Hcy）在重组人促红素（rHu-EPO）改善急性脑梗死患者认知功能障碍中的作用。方法 将2017年1月~2018年12月收入西安市第三医院ICU的54例急性脑梗死合并认知功能障碍患者随机分为对照组（28例）和治疗组（26例），对照组进行急性脑梗死的常规治疗，治疗组在常规治疗的基础上加用rHu-EPO 30 IU/kg皮下注射。检测治疗前和治疗后血清EPO、Hcy水平，Pearson相关分析判别血清Hcy与EPO水平的相关性。采用蒙利特尔认知评估量表（MoCA）评估治疗前后患者神经认知功能的变化，采用美国国立卫生研究院神经功能缺损评分标准（NIHSS）评估治疗前后患者神经功能缺损评分的变化。结果 两组治疗4周后血清EPO水平、MoCA总分、语言能力、延迟回忆能力评分高于治疗前，同型半胱氨酸（Hcy）水平、NIHSS评分低于治疗前，且治疗组优于对照组（P＜0.05），Pearson相关分析显示血清Hcy与EPO水平呈负相关。结论 在常规治疗的基础上加用rHu-EPO对急性脑梗死患者认知功能具有改善作用，其机制可能与降低Hcy水平有关。
Abstract:
Objective To investigate the role of homocysteine(Hcy)in the improvement of the cognitive dysfunction of patients with acute cerebral infarction by recombinant human erythropoietin (rHu-EPO).Methods 54 patients with acute cerebral infarction combined with cognitive dysfunction who were admitted to the ICU of Xi’an Third Hospital from January 2017 to December 2018 were randomly divided into a control group (28 cases) and a treatment group (26 cases). For the conventional treatment of acute cerebral infarction, the treatment group was injected with rHu-EPO 30 IU/kg subcutaneously on the basis of conventional treatment. Serum EPO and Hcy levels were detected before and after treatment, and Pearson correlation analysis was used to determine the correlation between serum Hcy and EPO levels. The Monlitell Cognitive Assessment Scale (MoCA) was used to evaluate the changes in the patients’ neurocognitive function before and after treatment, and the National Institutes of Health Neurological Impairment Score (NIHSS) was used to assess the changes in the patients’ neurological deficit score before and after treatment.Results After 4 weeks of treatment, the serum EPO levels, MoCA total scores, language ability, and delayed recall scores of the two groups were higher than before treatment, and homocysteine (Hcy) levels and NIHSS scores were lower than before treatment, and the treatment group was better than the control group(P＜0.05).Pearson correlation analysis showed that serum Hcy and EPO levels were negatively correlated. Conclusion The addition of rHu-EPO on the basis of conventional treatment could improve the cognitive function of patients with acute cerebral infarction, and its mechanism might be related to the reduction of Hcy levels.

参考文献/References:

[1]Steppich B,Groha P,Ibrahim T,et al.Effect of Erythropoietin in patients with acute myocardial infarction:five-year results of the REVIVAL-3 trial[J].BMC Cardiovasc Disord,2017,17(1):38. [2]Jiang CJ,Wang ZJ,Zhao YJ,et al.Erythropoietin reduces apoptosis of brain tissue cells in rats after cerebral ischemia/reperfusion injury:a characteristic analysis using magnetic resonance imaging[J].Neural Regen Res,2016,11(9):1450-1455. [3]Vinberg M,Miskowiak K,HoejmanP,et al.The effect of recombinant erythropoietin on plasma brain derived neurotrophic factor levels in patients with affective disorders:a randomised controlled study[J].PLoS One.2015,10(5):e0127629. [4]Tojo Y,Sekine H,Hirano I,et al.Hypoxia Signaling Cascade for Erythropoietin Production in Hepatocytes[J].Mol Cell Biol,2015,35(15):2658-2672. [5]Torres J,Ishida K.Neuroprotection after major cardiovascular surgery[J].Curr Treat Options Neurol,2015,17(7):357. [6]Larpthaveesarp A,Ferriero DM,Gonzalez FF.Growth factors for the treatment of ischemic brain injury(growth factor reatment)[J].Brain Sci,2015,5(2):165-177. [7]祝慧凤,徐晓玉,万东,等.促红素促脑血管新生机制研究进展[J].中国药理学通报.2011,27(4):451-454. [8]Wang W,Li D,Li Q,et al.Erythropoietin promotes peripheral nerve regeneration in rats by upregulating expression of insulin-like growth factor-1[J].Arch Med Sci,2015,11(2):433-437. [9]刘鸣,贺茂林.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246-257. [10]戴轶伟,季燕.急性脑梗死后认知功能障碍相关影响因素[J].医学综述,2016,22(21):4316-4318. [11]Lu J,Jiang L,Zhu H,et al.Hypoxia-inducible factor-1α and erythropoietin expression in the hippocampus of neonatal rats following hypoxia-ischemia[J].J NanosciNanotechnol,2014,14(8):5614-5619. [12]Grote Beverborg N,Verweij N,Klip IT,et al.Erythropoietin in the general population:reference ranges and clinical,biochemical and genetic correlates[J].PLoS One,2015,10(4):e0125215. [13]于代华,蒋玮,彭细娟,等.促红素预处理对大鼠脑缺血再灌注损伤的影响[J].中华危重症医学杂志(电子版),2013,12(6):339-343. [14]Jeong JH,Kang SH,Kim JH,et al.Protective effects of poly(lactic-co-glycolic acid)nanoparticles loaded with erythropoietin stabilized by sodium cholate against glutamate-induced neurotoxicity[J].J Nanosci Nanotechnol,2014,14(11):8365-8371. [15]Xiong Y,Mahmood A,Meng Y,et al.Delayed administration of erythropoietin reducing hippocampal cell loss,enhancing angiogenesis and neurogenesis, and improving functional outcome following traumatic brain injury in rats:comparison of treatment with single and triple dose[J].J Neurosurg,2010,113(3):598-608. [16]张士永,高天,孙剑,等.血浆同型半胱氨酸水平与脑梗死的相关性研究[J].中国医药导报,2011,8(11):78-79. [17]Holmes MV,Newcombe P,Hubacek JA,et al.Effect modification by population dietary folate on the association between MTHFR genotype,homocysteine,and stroke risk:a meta-analysis of genetic studies and randomised trials[J].Lancet,2011,378(9791):584-594. [18]付平,陈肖蕾.合理应用人促红素治疗肾性贫血[J].中国实用内科杂志,2012,32(12):900-902. [19]Hasegawa T,Zhao J,Fuller DS,et al.Erythropoietin Hyporesponsiveness in Dialysis Patients:Possible Role of Statins[J].Am J Nephrol,2017,46(1):11-17.

相似文献/References:

[1]袁 帅,邢晓博,李 晓,等.MTHFR基因多态性与中年男性冠状动脉病变程度的相关研究[J].医学信息,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
　YUAN Shuai,XING Xiao-bo,LI Xiao,et al.Association of MTHFR Gene Polymorphism with Coronary Artery Lesions in Middle-aged Men[J].Medical Information,2018,31(19):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
[2]王淑娟,林祥灿.血浆NT-proBNP水平与同型半胱氨酸对 糖尿病合并心房颤动的相关性研究[J].医学信息,2018,31(14):169.[doi:10.3969/j.issn.1006-1959.2018.14.053]
　WANG Shu-juan,LIN Xiang-can.Correlation between Plasma NT-proBNP level and Homocysteine in Patients with Diabetes Mellitus Complicated with Atrial Fibrillation[J].Medical Information,2018,31(19):169.[doi:10.3969/j.issn.1006-1959.2018.14.053]
[3]张 波.冠心病心绞痛患者血浆同型半胱氨酸水平与 中医证候要素痰、瘀的回归性研究[J].医学信息,2018,31(16):142.[doi:10.3969/j.issn.1006-1959.2018.16.045]
　ZHANG Bo.A Regression Study of Plasma Homocysteine Level and Phlegm and Blood Stasis in Patients with Angina Pectoris of Coronary Heart Disease[J].Medical Information,2018,31(19):142.[doi:10.3969/j.issn.1006-1959.2018.16.045]
[4]吴彦卿.妊娠期同型半胱氨酸和血脂水平对重度子痫前期的预测价值[J].医学信息,2018,31(16):157.[doi:10.3969/j.issn.1006-1959.2018.16.050]
　WU Yan-qing.Predictive Value of Homocysteine and Blood Lipid Levels during Pregnancy in Severe Preeclampsia[J].Medical Information,2018,31(19):157.[doi:10.3969/j.issn.1006-1959.2018.16.050]
[5]闫宇梅.血清胱抑素C及同型半胱氨酸与2型糖尿病 视网膜病变的相关性分析[J].医学信息,2018,31(17):89.[doi:10.3969/j.issn.1006-1959.2018.17.027]
　YAN Yu-mei.Correlation between Serum Cystatin C and Homocysteine and Type 2 Diabetic Retinopathy[J].Medical Information,2018,31(19):89.[doi:10.3969/j.issn.1006-1959.2018.17.027]
[6]张晓瑛,李雯彬,张志虹,等.同型半胱氨酸、抑郁症状与冠心病的研究进展[J].医学信息,2019,32(11):22.[doi:10.3969/j.issn.1006-1959.2019.11.007]
　ZHANG Xiao-ying,LI Wen-bin,ZHANG Zhi-hong,et al.Advances in Research on Homocysteine,Depressive Symptoms and Coronary Heart Disease[J].Medical Information,2019,32(19):22.[doi:10.3969/j.issn.1006-1959.2019.11.007]
[7]李慧丹,赵文鸽,王学惠.Nox4在同型半胱氨酸介导的动脉粥样硬化中作用的研究[J].医学信息,2019,32(15):45.[doi:10.3969/j.issn.1006-1959.2019.15.015]
　LI Hui-dan,ZHAO Wen-ge,WANG Xue-hui.Research on the Role of Nox4 in Homocysteine-mediated Atherosclerosis[J].Medical Information,2019,32(19):45.[doi:10.3969/j.issn.1006-1959.2019.15.015]
[8]赵晓静,鲁作华,韩书光,等.同型半胱氨酸、C反应蛋白及心肌标志物与冠心病早期诊断的相关研究[J].医学信息,2022,35(14):135.[doi:10.3969/j.issn.1006-1959.2022.14.034]
　ZHAO Xiao-jing,LU Zuo-hua,HAN Shu-guang,et al.Correlation of Homocysteine, C-reactive Protein and Myocardial Markers with Early Diagnosis of Coronary Heart Disease[J].Medical Information,2022,35(19):135.[doi:10.3969/j.issn.1006-1959.2022.14.034]
[9]朱丽娜,王宗立,顾萌萌.UA、Hcy和FIB与颈动脉粥样硬化斑块及 脑梗死关系的分析[J].医学信息,2019,32(18):173.[doi:10.3969/j.issn.1006-1959.2019.18.061]
　ZHU Li-na,WANG Zong-li,GU Meng-meng.Analysis of the Relationship Among UA, Hcy，FIB and Carotid Atherosclerotic Plaque， Cerebral Infarction[J].Medical Information,2019,32(19):173.[doi:10.3969/j.issn.1006-1959.2019.18.061]
[10]周忠梅.前列地尔辅助常规治疗冠心病不稳定型心绞痛的效果及对患者凝血功能的影响[J].医学信息,2019,32(20):147.[doi:10.3969/j.issn.1006-1959.2019.20.046]
　ZHOU Zhong-mei.Effect of Alprostadil on Routine Treatment of Unstable Angina Pectoris in Coronary Heart Disease and its Effect on Coagulation Function in Patients[J].Medical Information,2019,32(19):147.[doi:10.3969/j.issn.1006-1959.2019.20.046]

更新日期/Last Update: 1900-01-01